Clinical Trial

Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to develop a predictive model using deep learning and radiomics to assess the likelihood of lymph node metastasis in patients with early-stage esophageal squamous cell carcinoma (ESCC). Lymph node metastasis is a critical factor in determining the treatment approach and prognosis for ESCC patients. By analyzing medical imaging data, we hope to create a non-invasive method that can assist doctors in making more accurate treatment decisions. This research could improve patient outcomes by enabling earlier and more tailored interventions.
Trial Details
NCT Number NCT07050576
Lead Sponsor The First Affiliated Hospital of Anhui Medical University
Conditions ESCC, Lymph Node Metastasis, Radiomics
Enrollment 500 participants
Start Date 2024-05-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-03